Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Qiu Gu

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
BMJ Open|June 24, 2022
Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in ChinaHai-Yan Wang, Hong-Qiu Gu, Qi Zhou, et al.
Stroke and Vascular Neurology|July 26, 2023
Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attackWei Li, Hao Li, Chaoxia Lu, et al.
JAMA Network Open|July 29, 2021
Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in ChinaHong-Qiu Gu, Xin Yang, Chun-Juan Wang, et al.
JAMA Network Open|August 13, 2021
Clinical Characteristics, Management, and In-Hospital Outcomes in Patients With Stroke or Transient Ischemic Attack in ChinaHong-Qiu Gu, Xin Yang, Chun-Juan Wang, et al.
The Lancet. Neurology|December 1, 2024
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trialShuya Li, Hong-Qiu Gu, Baoyu Feng, et al.
Stroke and Vascular Neurology|September 22, 2022
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort studyXin Qiu, Yalun Dai, Si Cheng, et al.
Science Bulletin|June 3, 2023
U-shaped association between low-density lipoprotein cholesterol levels and risk of all-cause mortality mediated by post-stroke infection in acute ischemic strokeZi-Mo Chen, Hong-Qiu Gu, Jing-Lin Mo, et al.
Innovation (Cambridge (Mass.))|November 11, 2024
Beyond low-density lipoprotein cholesterol levels: Impact of prior statin treatment on ischemic stroke outcomesZi-Mo Chen, Jing-Lin Mo, Kai-Xuan Yang, et al.
Stroke and Vascular Neurology|August 23, 2020
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke CollaborationsYong-Jun Wang, Zi-Xiao Li, Hong-Qiu Gu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 20, 2022
Short-term effect of PM2.5 on stroke in susceptible populations: A case-crossover studyMeng Wang, Ying Han, Chun-Juan Wang, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
BMJ Open|June 24, 2022
Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in ChinaHai-Yan Wang, Hong-Qiu Gu, Qi Zhou, et al.
Stroke and Vascular Neurology|July 26, 2023
Neglected Mendelian causes of stroke in adult Chinese patients who had an ischaemic stroke or transient ischaemic attackWei Li, Hao Li, Chaoxia Lu, et al.
JAMA Network Open|July 29, 2021
Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in ChinaHong-Qiu Gu, Xin Yang, Chun-Juan Wang, et al.
JAMA Network Open|August 13, 2021
Clinical Characteristics, Management, and In-Hospital Outcomes in Patients With Stroke or Transient Ischemic Attack in ChinaHong-Qiu Gu, Xin Yang, Chun-Juan Wang, et al.
The Lancet. Neurology|December 1, 2024
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trialShuya Li, Hong-Qiu Gu, Baoyu Feng, et al.
Stroke and Vascular Neurology|September 22, 2022
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort studyXin Qiu, Yalun Dai, Si Cheng, et al.
Science Bulletin|June 3, 2023
U-shaped association between low-density lipoprotein cholesterol levels and risk of all-cause mortality mediated by post-stroke infection in acute ischemic strokeZi-Mo Chen, Hong-Qiu Gu, Jing-Lin Mo, et al.
Innovation (Cambridge (Mass.))|November 11, 2024
Beyond low-density lipoprotein cholesterol levels: Impact of prior statin treatment on ischemic stroke outcomesZi-Mo Chen, Jing-Lin Mo, Kai-Xuan Yang, et al.
Stroke and Vascular Neurology|August 23, 2020
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke CollaborationsYong-Jun Wang, Zi-Xiao Li, Hong-Qiu Gu, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 20, 2022
Short-term effect of PM2.5 on stroke in susceptible populations: A case-crossover studyMeng Wang, Ying Han, Chun-Juan Wang, et al.
Pageof 8